Cancer Communications
indexed by SCI
BMC

About the cover
About the cover

Feb. 2013; Volume 32 Issue 2

February 27, 2004, Roche announced that Genentech has received approval from the US Food and Drug Administration (FDA) for Avastin (bevacizumab, rhuMAb-VEGF), an innovative new cancer drug, to be used with intravenous 5-Fluorouracil-based chemotherapy as treatment for patients with previously untreated metastatic cancer of the colon or rectum (first-line treatment).


Conference Report
The Sino-French 2012 Conference in Thoracic Oncology:an international academic platform for in-depth exchange on comprehensive research
Dong-Rong Situ, Philippe Dartevelle, Thierry Le Chevalier, Lan-Jun Zhang
[ Abstract  2345]   [ PDF Full-text  2488]     [ HTML PMC ]  Page: 53-58  Epub: 2013-1-18  doi: 10.5732/cjc.012.10321
Editorial
Molecular markers as therapeutic targets in lung cancer
Hsin-Hui Tseng, Biao He
[ PDF Full-text  1730]    Pages: 59-62    Epub: 2013-2-1
Review
The genetics and biology of KRAS in lung cancer
Peter M. K. Westcott, Minh D. To
[ Abstract  2834]   [ PDF Full-text  2918]     [ HTML PMC ]  Page: 63-70  Epub: 2012-7-2  doi: 10.5732/cjc.012.10098
The role of stem cells in airway repair: implications for the origins of lung cancer
Michael S. Mulvihill, Johannes R. Kratz, Patrick Pham, David M. Jablons, Biao He
[ Abstract  2859]   [ PDF Full-text  4361]     [ HTML PMC ]  Page: 71-74  Epub: 2012-11-1  doi: 10.5732/cjc.012.10097
Regulation of tumor cell migration by protein tyrosine phosphatase (PTP)-proline-, glutamate-, serine-,and threonine-rich sequence (PEST)